Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02715765 · ClinicalTrials.gov registry record · NA
The Use of Transcranial Electrical Stimulation for Hallucinations
A NA study, sponsored by University of Minnesota.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02715765 is a NA study that was terminated before completion, run by University of Minnesota. The registered enrollment target is 3 participants.
The verdict
NCT02715765, a NA study, was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Schizophrenia is a serious mental health disorder that affects approximately 1% of the population. Auditory hallucinations are present in as many as 50-75% of patients with this diagnosis. The hallucinations experienced by patients vary greatly and can severely impact an individual's ability to function on a daily basis. In approximately 25-30% of these patients, medication is an ineffective mechanism for managing these symptoms. These hallucinations are known as medication refractory auditory hallucination (MRAH). For those whose auditory hallucinations do not respond to medication, non-surgical brain stimulation (NBS) has recently shown promise as a therapeutic intervention. Two specific types of NBS, called transcranial direct current stimulation (tDCS) and transcranial random noise stimulation (tRNS), seem particularly well suited to treating MRAH. They have yet to be compared to each other in large samples of patients with MRAH. The goal of the study is to investigate whether tRNS and tDCS are effective in the treatment of MRAH and if one is better than the other when compared directly.
Interventions
- DEVICE Transcranial Direct Current Stimulation
- DEVICE Transcranial Random Noise Stimulation
- DEVICE Transcranial Sham Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-07 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02715765
The ClinicalTrials.gov registry entry for NCT02715765 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Transcranial Direct Current Stimulation is the first listed.
NCT02715765 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02715765 about?
NCT02715765 is a clinical study titled "The Use of Transcranial Electrical Stimulation for Hallucinations". Schizophrenia is a serious mental health disorder that affects approximately 1% of the population. Auditory hallucinations are present in as many as 50-75% of patients with this diagnosis. The hallucinations experienced by patients vary greatly and can severely impact an individual's ability to func...
What is the current status of trial NCT02715765?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2016-07. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02715765?
The interventions under investigation include: Transcranial Direct Current Stimulation (DEVICE), Transcranial Random Noise Stimulation (DEVICE), Transcranial Sham Stimulation (DEVICE).
Who is sponsoring clinical trial NCT02715765?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.